About the MedTech SPIN category

Community space for MedTech SPIN - to exchange regulatory intelligence and experiences, particularly useful to those working in smaller companies.

The activities of the Medical Technologies SPIN include:

Technical input to the MSc in Medical Technologies Regulatory Affairs

The production of one-day training courses on Medical Technology topics including those which are part of the CRED programme

Input on device topics to TOPRA’s Introductory Courses

Development of the Medical Technologies Symposium as a parallel track for the TOPRA Annual Symposium

Contribution of material for special medical technology editions of the Regulatory Rapporteur

Members of the SPIN meet to exchange regulatory intelligence and experiences, particularly useful to those working in smaller companies.

Steering committee

  • Chair: Robin Stephens , CEO, Psephos Biomedica
  • Co-Chair: Dr Mehryar Behizad, FTOPRA , Director & Independent Quality and Regulatory Consultant, Pirus Consulting Ltd
  • Beata Wilkinson PhD, MTOPRA - Prinicipal Consultant– Biophoenix Ltd
  • Moji Ajeneye, MHRA, UK
  • Janis Bayley, Regulatory Scientist, Eli Lilly & Company Ltd, UK
  • Tim Chesworth, Senior Director-Combination Products, AstraZeneca, UK
  • John Deavin, Consultant in Pharmaceutical Regulation, Deavin Associates, UK
  • Howard Dobbs, Managing Director, Howard Dobbs Consulting Ltd, UK
  • Jonathan Hughes, Managing Director, JHRA Ltd, UK
  • Janine Jamieson, JCombinations AB, Sweden
  • Theresa Jeary, Technical Manager, Lloyds Register Quality Assurance Ltd, UK
  • Margareth Jorvid, CEO, Regulatory Affairs & Quality Assurance, Methra Uppsala AB, Sweden
  • Maria Mehlin, CMC Conformance Lead (EMEA), Pfizer Ltd, UK
  • Mika Reinikainen, Managing Director, AbNovo Ltd, UK
  • Angela Stokes, VP Regulatory Affairs Services, Synteract, UK
  • Neil Adams, Associate Director Regulatory Affairs, Illumina Inc
  • Ivan Perez Chamorro, CEO, MedBoard
  • Michael Kipping, Innovation Lead, Innovate UK